Golden Meditech Announces FY 2019/2020 Annual Results.
HONG KONG: Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces today its annual results for the year ended 31 March 2020 (the "Year").
Revenue of the Group decreased slightly by 2.7% year-on-year to HK$307,141,000. This was because the impact of COVID-19 outbreak was only started in early 2020. Among them, revenue generated from the healthcare services segment decreased by 9.6% year-on-year to HK$151,600,000, accounting for 49.4% of the Group's revenue; while the medical devices segment recorded a revenue increase of 3.2% year-on-year to HK$147,168,000, accounting for 47.9% of the Group's revenue.
The adjusted loss attributable to equity shareholders of the Company was HK$315,904,000, down 14.5% year-on-year; the adjusted basic loss per share was 10.8 HK cents, down 15.0% year-on-year. The decrease was mainly attributable to the decrease in adjusted operating loss, finance costs and the withholding tax on PRC dividend.
Mr. Feng Wen, Chairman of the Group, said, "The COVID-19 pandemic has affected the Group to a certain context, nevertheless, we are confident to deal with the tough time ahead, and will try our best to minimise the impact of the pandemic on the Group's results in anticipation of the challenging market environment. With respect to healthcare services, we will continue to build the predominant disciplines of our hospitals, fully tapping into the market potential of the premium healthcare services. At the same time, we will fully utilise the long-term competitiveness underpinned by the Group's nationwide marketing network to expand the sales channels and sales volume of medical devices. The Group will also further integrate its resources and strengthen the synergetic effect among its various business segments, so as to enhance its revenue and profitability."
Healthcare Services Segment
During the Year, the fluctuations in the performance of the healthcare services segment were mainly caused by a number of factors, including the expansion work and relocation of Shanghai East International Medical Center, the modification work to the laboratory and the impact of the pandemic. Revenue from hospital businesses, medical insurance administration business and cells and tissues storage and genetic testing services businesses have decreased by 1.3%, 28.5% and 88.9% year-on-year to...
To continue reading
Request your trial